GMO Internet Group Fully Opens R&D Facility Dedicated to Humanoid Robots, the “GMO Humanoid Lab Shibuya Showroom”

A report dated October 6, 2026, said, “GMO Internet Group Fully Opens R&D Facility Dedicated to Humanoid Robots, the ‘GMO Humanoid Lab Shibuya Showroom.’” This newspaper has not been able to verify the primary source, so readers should consult the original report for details.

Commercializing humanoid robots requires not only selling the machines but also providing support for maintenance and testing. GMO Internet Group appears to be building up sales, maintenance and R&D capabilities as parts of an integrated effort. For users, post-deployment operations will be an issue; for suppliers, the testing environment will be a concern.

The key point is that GMO Internet Group has established a dedicated R&D facility in Shibuya for humanoid robots, going beyond simply selling, transporting and maintaining them. Previous reports said the company was discussing an expansion of the products it handles in its humanoid robot sales business, while a separate article covered moves involving dedicated vehicles and maintenance services. The addition of the “GMO Humanoid Lab Shibuya Showroom” makes it easier to see how the company could connect points of contact before and after deployment within a single organization. This newspaper’s related article “GMO Discusses Expanding Its Humanoid Robot Product Lineup” covers sales, while [“GMO AI & Robotics Trading to Introduce Japan’s First Dedicated Humanoid Robot Maintenance Vehicle, the ‘GMO Humanoid Ambulance,’ in September 2026”](/news/gmo-ai-roboteikusu-shouji-kokunai-hatsu-no-hitogata-robotto-6572e9) covers operational support. The new facility appears to make its development and testing function—the link between those areas—explicit. The question, in turn, is whether it will serve not simply as an exhibition space but as a base for receiving, maintaining, testing and improving robots. From an industry perspective, humanoid robots are difficult to operate continuously without the machines themselves, maintenance capabilities, transportation and real-world testing environments. GMO’s moves suggest it is building these supporting functions in-house. However, public information does not currently show the facility’s size or equipment, or what kinds of tests it will conduct. Readers should consult the original report for details.

For companies working with humanoid robots in Japan, creating support for maintenance and trials after sales could become a concrete challenge. The facility may draw attention to demand for robotics-related services and maintenance vehicles in Japan, as a model that brings R&D and exhibition functions together in an urban area.